PSC

H&H North America, Owners of Zesty Paws & Solid Gold Pet, Achieves B Corp™ Certification

Retrieved on: 
Wednesday, January 31, 2024
Certification, PSC, Sustainability, Paw, Environment, Global health, Pet, Icon, Bottled water

ORLANDO, Fla., Jan. 31, 2024 /PRNewswire-PRWeb/ -- H&H North America is pleased to announce it is officially a Certified B Corporation™. This prestigious certification means H&H North America has met rigorous governance, environment, and sustainability standards, underscoring the company's commitment to socially responsible business practices. Zesty Paws, the #1 Selling Pet Supplement Brand in the USA*, and Solid Gold Pet, America's first holistic pet nutrition company, are the pet nutrition care brands of H&H North America, proudly B Corp™ certified.

Key Points: 
  • Zesty Paws and Solid Gold Pet are the pet nutrition care brands of H&H North America, proudly B Corp™ certified
    ORLANDO, Fla., Jan. 31, 2024 /PRNewswire-PRWeb/ -- H&H North America is pleased to announce it is officially a Certified B Corporation™.
  • This prestigious certification means H&H North America has met rigorous governance, environment, and sustainability standards, underscoring the company's commitment to socially responsible business practices.
  • Zesty Paws , the #1 Selling Pet Supplement Brand in the USA*, and Solid Gold Pet , America's first holistic pet nutrition company, are the pet nutrition care brands of H&H North America, proudly B Corp™ certified.
  • We're proud to be part of a global community of businesses that meet these high standards of social and environmental impact, and we're committed to building upon our promise of environmental responsibility here in North America.

Chemomab Therapeutics Announces New Publication Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis

Retrieved on: 
Tuesday, January 30, 2024
CCL24, Pathology, Role, Neutrophil, Patient, European, Therapy, Primary sclerosing cholangitis, Fibrosis, CMMB, Proteomics, In vitro, Potential, Orphan drug, CCL11, PSC, Myofibroblast, Health, TEL, Cell, Disease, CCL26, Fast Track, FDA, Protein, Doctor of Philosophy, Inflammation, Monocyte, Pharmaceutical industry

TEL AVIV, Israel, Jan. 30, 2024 /PRNewswire/ -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company focused on the discovery and development of innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced publication of proteomic analyses that further demonstrate the unique role of the soluble protein CCL24 in driving pathologies associated with the rare fibrotic liver disease primary sclerosing cholangitis (PSC). The new studies reinforce the extensive existing evidence showing that Chemomab's first-in-class CCL24-neutralizing antibody CM-101 can interrupt these destructive processes. The study, "The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data"1 has been published in the current online version of the peer-reviewed journal Cells.

Key Points: 
  • The new studies reinforce the extensive existing evidence showing that Chemomab's first-in-class CCL24-neutralizing antibody CM-101 can interrupt these destructive processes.
  • The study, " The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data "1 has been published in the current online version of the peer-reviewed journal Cells.
  • CM-101 is a first-in-class CCL24-neutralizing monoclonal antibody whose dual anti-inflammatory and anti-fibrotic activity has demonstrated disease modifying potential in nonclinical studies of PSC and other fibro-inflammatory disorders.
  • CM-101 has Orphan Drug designation for PSC in the U.S. and the European Union and was recently awarded Fast Track designation by the FDA for the treatment of PSC in adults.

Genel Energy PLC: Trading and operations update

Retrieved on: 
Tuesday, January 30, 2024
KRG, Total, Miran, Interest, Federal, Award, Organization, ITP, PSC, Hearing, Petroleum industry, Cryptocurrency

Genel Energy plc ('Genel' or 'the Company') issues the following trading and operations update in advance of the Company's full-year 2023 results, which are scheduled for release on 26 March 2024.

Key Points: 
  • Genel Energy plc ('Genel' or 'the Company') issues the following trading and operations update in advance of the Company's full-year 2023 results, which are scheduled for release on 26 March 2024.
  • The information contained herein has not been audited and may be subject to further review.
  • We have cut all non-essential activity and significantly reduced spend, while developing a new source of income through domestic sales.
  • Genel’s claim is that the KRG’s termination of the PSCs was repudiatory and, as a consequence, is claiming substantial damages.

NetImpact CEO Venkatapathi "PV" Puvvada Named to Professional Services Council Executive Committee

Retrieved on: 
Tuesday, January 23, 2024
Executive Committee, PV, PSC, Government, Federation, Human, Management

FALLS CHURCH, Va., Jan. 23, 2024 /PRNewswire/ --  NetImpact Strategies, Inc. (NetImpact) announced that Venkatapathi "PV" Puvvada, Chief Executive Officer (CEO), has been elected to the Professional Services Council (PSC) Executive Committee by its Board of Directors at their recent annual meeting.

Key Points: 
  • FALLS CHURCH, Va., Jan. 23, 2024 /PRNewswire/ --  NetImpact Strategies, Inc. (NetImpact) announced that Venkatapathi "PV" Puvvada, Chief Executive Officer (CEO), has been elected to the Professional Services Council (PSC) Executive Committee by its Board of Directors at their recent annual meeting.
  • PSC Executive Committee is a subset of the board and provides leadership, guidance, and oversight to PSC and plays a key role in driving the organization's strategic priorities and success.
  • Today's announcement is the latest in a series of leadership appointments for Puvvada at PSC.
  • "We are thrilled to continue to have PV's engagement with the Executive Committee to help drive our future journey as an important voice for the government contracting industry."

PJM Appoints Former Maryland Regulator Jason Stanek to New Governmental Services Role

Retrieved on: 
Monday, January 22, 2024
House, Policy, Multimedia, Commerce, Electricity, State, PSC, Tulane University, Executive, PJM, PJM Interconnection, Maryland Public Service Commission, State government, News, Federal Energy Regulatory Commission, Energy

VALLEY FORGE, Pa. , Jan. 22, 2024 /PRNewswire/ -- PJM announces the appointment of Jason Stanek, former chair of the Maryland Public Service Commission, to the new role of Executive Director – Governmental Services.

Key Points: 
  • VALLEY FORGE, Pa. , Jan. 22, 2024 /PRNewswire/ -- PJM announces the appointment of Jason Stanek, former chair of the Maryland Public Service Commission, to the new role of Executive Director – Governmental Services.
  • Stanek will report to Sr. Vice President Asim Haque, whose department has been renamed Governmental & Member Services, emphasizing the importance of state and federal governments to PJM.
  • "Jason brings a wealth of experience to PJM that will benefit both PJM and its stakeholders," Haque said.
  • "He was a thoughtful, knowledgeable and independent regulator who will further bolster the depth and breadth of our engagement."

Proposed Electric School Bus Pilot Program Aimed to Help Maryland Achieve Climate Goals and Help Public Schools Meet Transportation Needs

Retrieved on: 
Thursday, January 18, 2024
Student, FirstEnergy, Driven, Health, McGettigan, Multimedia, Electricity, PSC, ESB, Safety, Maryland Public Service Commission, FE, EV, Transport, Atmosphere, Electric power

WILLIAMSPORT, Md., Jan. 18, 2024 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) subsidiary Potomac Edison has submitted a five-year Electric School Bus Pilot Program proposal to the Maryland Public Service Commission (PSC) intended to help the state reach its climate goals. The pilot supports Maryland's Climate Solutions Now Act of 2022, which requires any new school buses contracted or purchased by public school systems in the state to be zero emissions.

Key Points: 
  • WILLIAMSPORT, Md., Jan. 18, 2024 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) subsidiary Potomac Edison has submitted a five-year Electric School Bus Pilot Program proposal to the Maryland Public Service Commission (PSC) intended to help the state reach its climate goals.
  • Our pilot program is also intended to help the state meet climate goals by reducing greenhouse gas emissions, which will create cleaner air and improve overall health in local communities we serve."
  • To aid in the electric school bus (ESB) transition across Potomac Edison's Maryland service territory, the company will provide:
    Financial incentives for school districts to acquire and deploy ESBs.
  • The public school districts that opt to participate in the pilot program, will receive funding that reduces the cost difference between an electric school bus and an equivalent diesel-fueled bus.

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

Retrieved on: 
Tuesday, January 9, 2024
Bile, Woman, Hyperemesis gravidarum, Research, Biology, Hospital, Weight loss, MSS, FRS, Hepatology, University, ILT3, Liver disease, FGF19, GFRAL, LAIR1, Liver, Doctor of Philosophy, NASH, CRC, Pembrolizumab, Trial of the century, Neoplasm, NGM, SAN, PRS, Public health, Genetic epidemiology, Preterm birth, Vomiting, Cirrhosis, DCR, Dehydration, AASLD, Immunotherapy, Place of birth, Medicine, Pregnancy, Pre-eclampsia, Therapy, ELF, Patient, Bile acid malabsorption, Fibrosis, Nausea, Alkaline phosphatase, PSC, Gastrointestinal disease, CRN, IBS-D, Malnutrition, FDA, Biomarker, Pharmaceutical industry

NGM Bio also outlined its strategy to evolve clinical development of its product candidates aldafermin and NGM120 to focus on rare conditions characterized by significant unmet need.

Key Points: 
  • NGM Bio also outlined its strategy to evolve clinical development of its product candidates aldafermin and NGM120 to focus on rare conditions characterized by significant unmet need.
  • Recent landmark genetic research confirmed the link between this rare, devastating condition experienced during pregnancy to higher levels of GDF15.
  • Given our deep expertise in GDF15 biology, we believe we are well positioned to potentially pursue this indication for NGM120.
  • NGM Bio previously reported data from a randomized, double-blind, placebo-controlled Phase 2 study of aldafermin for the treatment of PSC.

PSC Group, a Portfolio Company of Aurora Capital Partners, Announces Expanded Last-Mile Logistics Solutions with Acquisition of Bayport Rail Terminal LLC

Retrieved on: 
Tuesday, January 9, 2024
Port, Heart, PSC, Chemical industry, BRT, Acquisition, Wells Fargo, The Company

With significant undeveloped acreage, BRT is uniquely positioned to continue to expand and serve the surrounding industry and port needs.

Key Points: 
  • With significant undeveloped acreage, BRT is uniquely positioned to continue to expand and serve the surrounding industry and port needs.
  • "The wide range of solutions and services provided by the Bayport Rail Terminal expands our existing capabilities, and we are thrilled to welcome it to the PSC family," said PSC CEO Joel Dickerson.
  • BRT marks the sixth acquisition completed by PSC Group since partnering with Aurora in 2019, including Prokar, Inc., Fryoux Tankerman Service, Akrotex Extrusion, Thermoplastics Services, Inc. and Steel Line Rail Services, LLC.
  • Wells Fargo Securities, LLC served as the exclusive financial advisor to US Development Group.

CES 2024: Panasonic Group to Exhibit Products, Technologies for Realizing Its Vision for Future Lifestyles

Retrieved on: 
Monday, January 8, 2024
Applied mechanics, Delta, MKII, B2B, Fisker Ocean, POC, OLED, IMU, Antioxidant, Transport, Mineral, Pleasure, Communication, Atmosphere, ELS, Natural Resources, Star, Wood, Health, Amazon Fire TV, Diorama, Exhibition, Knowledge, Fresco, PGI, Reproduction, Carbon, USB, Safety, Life, VR, Sound, PP, EVS, Electronics, Technics, Delta Sigma, Television, Weather, ABS, Electrode, Steam (service), Panasonic, Carbon footprint, Power inverter, Music, Fire, IEA, Particle size, Lens, System, HDR, Diffusion, Star Wars, Klipsch Audio Technologies, PSC, Infiniti, Temperature, PS, CO2, Airbourne

Introduces "Panasonic GREEN IMPACT," the Panasonic Group's commitment to achieving both a better life for people and a sustainable global environment.

Key Points: 
  • Introduces "Panasonic GREEN IMPACT," the Panasonic Group's commitment to achieving both a better life for people and a sustainable global environment.
  • The Panasonic Group will introduce a wide range of in-vehicle device solutions that contribute to the adoption of EVs.
  • For now, Panasonic is expanding verification with electric power companies and transportation companies to accelerate verification of business scaling.
  • The Panasonic Group has set forth its long-term environmental vision, "Panasonic GREEN IMPACT," with the aim of achieving both a better life and a sustainable global environment for all.

Crestwood Advisors Announces New President

Retrieved on: 
Monday, January 8, 2024
PSC, Partner, Chair, Empath, Harvard University, Growth, The Boston Foundation, CFA, Partner (business rank), Marketing

Boston, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Crestwood Advisors (“Crestwood”), a boutique investment advisory and wealth management firm based in Boston and with offices in Connecticut and Rhode Island, is pleased to announce the appointment of Leah R. Sciabarrasi, CFP® as President, effective January 1, 2024.

Key Points: 
  • Boston, Mass., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Crestwood Advisors (“Crestwood”), a boutique investment advisory and wealth management firm based in Boston and with offices in Connecticut and Rhode Island, is pleased to announce the appointment of Leah R. Sciabarrasi, CFP® as President, effective January 1, 2024.
  • “Leah’s appointment as President is a natural evolution of her leadership within Crestwood,” said CEO/Managing Partner and Portfolio Manager Michael A. Eckton, CFA .
  • “I am honored to take on the expanded role of President at Crestwood Advisors,” said Leah, who will continue to serve as Managing Partner and Wealth Manager.
  • Last year, Crestwood Advisors celebrated its 20th anniversary , highlighting two decades of dedication to client success and financial excellence.